Literature DB >> 24970880

New insights into stages of lyme disease symptoms from a novel hospital-based registry.

Jessika Lobraico1, Amber Butler2, Joann Petrini2, Ramin Ahmadi2.   

Abstract

BACKGROUND: Western Connecticut Health Network created the Lyme Disease Registry in response to the community's request and clinical need for more Lyme disease research. The registry includes acute, recovered, and persistently symptomatic patients to better define the different stages of the disease. The design of the registry was guided by community and clinician input through a community-based participatory research process.
METHODS: Registry participants are asked questions regarding their diagnosis, symptoms, treatments, recovery, and satisfaction with the Registry. A blood specimen is also collected and stored at the initial appointment.
RESULTS: The Lyme Disease Registry has enrolled 256 participants, 24% are acute cases, 45% are persistently symptomatic cases, and 31% are recovered cases. The symptoms experienced by the group of patients with persistent symptoms had unexpectedly strong overlap with those experienced by acutely infected patients.
CONCLUSION: The difference between symptoms in the acutely infected patients and those experiencing persistent symptoms is not as large as initially thought.
© The Author(s) 2014.

Entities:  

Keywords:  community health; disease management; health outcomes; prevention; primary care

Mesh:

Year:  2014        PMID: 24970880     DOI: 10.1177/2150131914540693

Source DB:  PubMed          Journal:  J Prim Care Community Health        ISSN: 2150-1319


  7 in total

1.  The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.

Authors:  Alison W Rebman; Kathleen T Bechtold; Ting Yang; Erica A Mihm; Mark J Soloski; Cheryl B Novak; John N Aucott
Journal:  Front Med (Lausanne)       Date:  2017-12-14

Review 2.  Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease.

Authors:  Alison W Rebman; John N Aucott
Journal:  Front Med (Lausanne)       Date:  2020-02-25

3.  Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study.

Authors:  Alison W Rebman; Ting Yang; John N Aucott
Journal:  BMJ Open       Date:  2021-01-13       Impact factor: 2.692

4.  Contrast Sensitivity Loss in Patients With Posttreatment Lyme Disease.

Authors:  Alison W Rebman; Ting Yang; John N Aucott; Erica A Mihm; Sheila K West
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

5.  Suicide and Lyme and associated diseases.

Authors:  Robert C Bransfield
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-16       Impact factor: 2.570

Review 6.  Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist's Clinical Practice.

Authors:  Robert C Bransfield
Journal:  Healthcare (Basel)       Date:  2018-08-25

7.  Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.

Authors:  Samuel Shor; Christine Green; Beatrice Szantyr; Steven Phillips; Kenneth Liegner; Joseph Jr Burrascano; Robert Bransfield; Elizabeth L Maloney
Journal:  Antibiotics (Basel)       Date:  2019-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.